
ID   MP2K7_HUMAN             Reviewed;         419 AA.
AC   O14733; B2R9S5; D6W659; O14648; O14816; O60452; O60453; Q1PG43;
AC   Q8IY10;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   19-MAR-2014, entry version 139.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 7;
DE            Short=MAP kinase kinase 7;
DE            Short=MAPKK 7;
DE            EC=2.7.12.2;
DE   AltName: Full=JNK-activating kinase 2;
DE   AltName: Full=MAPK/ERK kinase 7;
DE            Short=MEK 7;
DE   AltName: Full=Stress-activated protein kinase kinase 4;
DE            Short=SAPK kinase 4;
DE            Short=SAPKK-4;
DE            Short=SAPKK4;
DE   AltName: Full=c-Jun N-terminal kinase kinase 2;
DE            Short=JNK kinase 2;
DE            Short=JNKK 2;
GN   Name=MAP2K7; Synonyms=JNKK2, MEK7, MKK7, PRKMK7, SKK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart, and Skeletal muscle;
RX   PubMed=9372971;
RA   Wu Z., Wu J., Jacinto E., Karin M.;
RT   "Molecular cloning and characterization of human JNKK2, a novel jun
RT   NH2-terminal kinase-specific kinase.";
RL   Mol. Cell. Biol. 17:7407-7416(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND ENZYME
RP   REGULATION.
RX   PubMed=9312068; DOI=10.1074/jbc.272.40.24751;
RA   Lu X., Nemoto S., Lin A.;
RT   "Identification of c-Jun NH2-terminal protein kinase (JNK)-activating
RT   kinase 2 as an activator of JNK but not p38.";
RL   J. Biol. Chem. 272:24751-24754(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND VARIANT PHE-259.
RC   TISSUE=Fetal kidney;
RX   PubMed=9535930; DOI=10.1074/jbc.273.15.9344;
RA   Foltz I.N., Gerl R.E., Wieler J.S., Luckach M., Salmon R.A.,
RA   Schrader J.W.;
RT   "Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly
RT   conserved c-Jun N-terminal kinase/stress-activated protein kinase
RT   (JNK/SAPK) activated by environmental stresses and physiological
RT   stimuli.";
RL   J. Biol. Chem. 273:9344-9351(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16442502; DOI=10.1016/j.bbrc.2005.12.223;
RA   Michael L., Swantek J., Robinson M.J.;
RT   "Cloning and expression of human mitogen-activated protein kinase
RT   kinase 7gamma1.";
RL   Biochem. Biophys. Res. Commun. 341:679-683(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION IN
RP   PHOSPHORYLATION OF MAPK8/JNK1 AND MAPK9/JNK2.
RA   Yang J., New L., Yong J., Han J., Su B.;
RT   "Molecular cloning of human JNKK2 reveals a novel kinase module for c-
RT   Jun N-terminal kinase activation.";
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-260 (ISOFORMS 1/4).
RX   PubMed=9207092; DOI=10.1073/pnas.94.14.7337;
RA   Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J.;
RT   "Mitogen-activated protein kinase kinase 7 is an activator of the c-
RT   Jun NH2-terminal kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7337-7342(1997).
RN   [10]
RP   INTERACTION WITH MAPK8IP1/JIP1 AND MAPK8IP2/JIP2.
RX   PubMed=10490659;
RA   Yasuda J., Whitmarsh A.J., Cavanagh J., Sharma M., Davis R.J.;
RT   "The JIP group of mitogen-activated protein kinase scaffold
RT   proteins.";
RL   Mol. Cell. Biol. 19:7245-7254(1999).
RN   [11]
RP   CLEAVAGE BY ANTHRAX LETHAL FACTOR.
RX   PubMed=11104681; DOI=10.1042/0264-6021:3520739;
RA   Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C.;
RT   "Susceptibility of mitogen-activated protein kinase kinase family
RT   members to proteolysis by anthrax lethal factor.";
RL   Biochem. J. 352:739-745(2000).
RN   [12]
RP   INTERACTION WITH MAPK8IP3/JIP3.
RX   PubMed=12189133; DOI=10.1074/jbc.M202004200;
RA   Matsuura H., Nishitoh H., Takeda K., Matsuzawa A., Amagasa T., Ito M.,
RA   Yoshioka K., Ichijo H.;
RT   "Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-
RT   JNK signaling pathway. A new mode of regulation of the MAP kinase
RT   cascade.";
RL   J. Biol. Chem. 277:40703-40709(2002).
RN   [13]
RP   DOMAIN.
RX   PubMed=15866172; DOI=10.1016/j.molcel.2005.04.001;
RA   Takekawa M., Tatebayashi K., Saito H.;
RT   "Conserved docking site is essential for activation of mammalian MAP
RT   kinase kinases by specific MAP kinase kinase kinases.";
RL   Mol. Cell 18:295-306(2005).
RN   [14]
RP   INTERACTION WITH VRK2.
RX   PubMed=18286207; DOI=10.1371/journal.pone.0001660;
RA   Blanco S., Sanz-Garcia M., Santos C.R., Lazo P.A.;
RT   "Modulation of interleukin-1 transcriptional response by the
RT   interaction between VRK2 and the JIP1 scaffold protein.";
RL   PLoS ONE 3:E1660-E1660(2008).
RN   [15]
RP   REVIEW ON ENZYME REGULATION.
RX   PubMed=17496909; DOI=10.1038/sj.onc.1210392;
RA   Raman M., Chen W., Cobb M.H.;
RT   "Differential regulation and properties of MAPKs.";
RL   Oncogene 26:3100-3112(2007).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   REVIEW ON FUNCTION.
RX   PubMed=20801953; DOI=10.1093/jb/mvq098;
RA   Asaoka Y., Nishina H.;
RT   "Diverse physiological functions of MKK4 and MKK7 during early
RT   embryogenesis.";
RL   J. Biochem. 148:393-401(2010).
RN   [18]
RP   INTERACTION WITH RASSF7.
RX   PubMed=21278800; DOI=10.1038/cdd.2010.137;
RA   Takahashi S., Ebihara A., Kajiho H., Kontani K., Nishina H.,
RA   Katada T.;
RT   "RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting
RT   the activity of phosphorylated-MKK7.";
RL   Cell Death Differ. 18:645-655(2011).
RN   [19]
RP   REVIEW ON REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=21333379; DOI=10.1016/j.ejcb.2010.11.008;
RA   Haeusgen W., Herdegen T., Waetzig V.;
RT   "The bottleneck of JNK signaling: molecular and functional
RT   characteristics of MKK4 and MKK7.";
RL   Eur. J. Cell Biol. 90:536-544(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 101-405.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of human mitogen-activated protein kinase kinase 7
RT   activated mutant (s287d, t291d).";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-118; CYS-138; CYS-162; HIS-162 AND
RP   THR-195.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity protein kinase which acts as an
CC       essential component of the MAP kinase signal transduction pathway.
CC       Essential component of the stress-activated protein kinase/c-Jun
CC       N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4,
CC       is the one of the only known kinase to directly activate the
CC       stress-activated protein kinase/c-Jun N-terminal kinases
CC       MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and
CC       MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they
CC       differ in their preference for the phosphorylation site in the
CC       Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for
CC       phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr
CC       residue. The monophosphorylation of JNKs on the Thr residue is
CC       sufficient to increase JNK activity indicating that MAP2K7/MKK7 is
CC       important to trigger JNK activity, while the additional
CC       phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal
CC       JNK activation. Has a specific role in JNK signal transduction
CC       pathway activated by proinflammatory cytokines. The MKK/JNK
CC       signaling pathway is also involved in mitochondrial death
CC       signaling pathway, including the release cytochrome c, leading to
CC       apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation by specific MAP
CC       kinase kinase kinases such as MAP3K1/MEKK1, MAP3K3/MEKK3,
CC       MAP3K11/MLK3 and MAP3K12/DLK.
CC   -!- SUBUNIT: Interacts with isoform 1 of VRK2. Interacts (via its D
CC       domain) with its substrates MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3
CC       (By similarity). Interacts (via its DVD domain) with MAP3Ks
CC       activators like MAP3K5/ASK1 and MAP3K1/MEKK1 (By similarity).
CC       Interacts with MAPK8IP1/JIP1, MAPK8IP2/JIP2 and MAPK8IP3/JIP3
CC       scaffold proteins. Interacts with RASSF7, the interaction promotes
CC       phosphorylation.
CC   -!- INTERACTION:
CC       O15519-1:CFLAR; NbExp=2; IntAct=EBI-492605, EBI-4567563;
CC       Q5S007:LRRK2; NbExp=3; IntAct=EBI-492605, EBI-5323863;
CC       O43318:MAP3K7; NbExp=2; IntAct=EBI-492605, EBI-358684;
CC       P45983:MAPK8; NbExp=3; IntAct=EBI-492627, EBI-286483;
CC       Q9UQF2:MAPK8IP1; NbExp=5; IntAct=EBI-492605, EBI-78404;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=O14733-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=O14733-2; Sequence=VSP_004883;
CC         Note=May be due to intron retention;
CC       Name=3; Synonyms=gamma1;
CC         IsoId=O14733-3; Sequence=VSP_022309;
CC       Name=4;
CC         IsoId=O14733-4; Sequence=VSP_022310;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; with highest level of expression
CC       in skeletal muscle. Isoform 3 is found at low levels in placenta,
CC       fetal liver, and skeletal muscle.
CC   -!- DOMAIN: The DVD domain (residues 377-400) contains a conserved
CC       docking site and is found in the mammalian MAP kinase kinases
CC       (MAP2Ks). The DVD sites bind to their specific upstream MAP kinase
CC       kinase kinases (MAP3Ks) and are essential for activation.
CC   -!- DOMAIN: The D domain (residues 37-57) contains a conserved docking
CC       site and is required for the binding to MAPK substrates.
CC   -!- PTM: Activated by phosphorylation on Ser-271 and Thr-275 by MAP
CC       kinase kinase kinases (MAP3Ks) (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB97813.1; Type=Erroneous termination; Positions=420; Note=Translated as stop;
CC       Sequence=AAB97813.1; Type=Frameshift; Positions=402, 410;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF014401; AAB88048.1; -; mRNA.
DR   EMBL; AF006689; AAB97813.1; ALT_SEQ; mRNA.
DR   EMBL; AF013588; AAC16272.1; -; mRNA.
DR   EMBL; AF013589; AAC16273.1; -; mRNA.
DR   EMBL; DQ445915; ABE03013.1; -; mRNA.
DR   EMBL; AF022805; AAC26142.1; -; mRNA.
DR   EMBL; AK313899; BAG36622.1; -; mRNA.
DR   EMBL; CH471139; EAW68964.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68968.1; -; Genomic_DNA.
DR   EMBL; BC038295; AAH38295.1; -; mRNA.
DR   EMBL; AF003199; AAB63374.1; -; mRNA.
DR   RefSeq; NP_660186.1; NM_145185.2.
DR   RefSeq; XP_005272546.1; XM_005272489.1.
DR   RefSeq; XP_005272547.1; XM_005272490.1.
DR   UniGene; Hs.531754; -.
DR   PDB; 2DYL; X-ray; 2.45 A; A=101-405.
DR   PDBsum; 2DYL; -.
DR   ProteinModelPortal; O14733; -.
DR   SMR; O14733; 53-402.
DR   BioGrid; 111595; 34.
DR   IntAct; O14733; 18.
DR   MINT; MINT-1378223; -.
DR   STRING; 9606.ENSP00000381066; -.
DR   BindingDB; O14733; -.
DR   ChEMBL; CHEMBL3530; -.
DR   DrugBank; DB00773; Etoposide.
DR   GuidetoPHARMACOLOGY; 2068; -.
DR   PhosphoSite; O14733; -.
DR   PaxDb; O14733; -.
DR   PRIDE; O14733; -.
DR   DNASU; 5609; -.
DR   Ensembl; ENST00000397979; ENSP00000381066; ENSG00000076984. [O14733-1]
DR   Ensembl; ENST00000397981; ENSP00000381068; ENSG00000076984. [O14733-4]
DR   Ensembl; ENST00000397983; ENSP00000381070; ENSG00000076984. [O14733-3]
DR   GeneID; 5609; -.
DR   KEGG; hsa:5609; -.
DR   UCSC; uc002mit.3; human. [O14733-1]
DR   UCSC; uc002miv.2; human. [O14733-4]
DR   CTD; 5609; -.
DR   GeneCards; GC19P007968; -.
DR   HGNC; HGNC:6847; MAP2K7.
DR   HPA; CAB004262; -.
DR   HPA; HPA001633; -.
DR   MIM; 603014; gene.
DR   neXtProt; NX_O14733; -.
DR   PharmGKB; PA284; -.
DR   eggNOG; COG0515; -.
DR   HOVERGEN; HBG108518; -.
DR   KO; K04431; -.
DR   OrthoDB; EOG7J9VPW; -.
DR   TreeFam; TF350701; -.
DR   BRENDA; 2.7.12.2; 2681.
DR   Reactome; REACT_120956; Cellular responses to stress.
DR   Reactome; REACT_6782; TRAF6 Mediated Induction of proinflammatory cytokines.
DR   Reactome; REACT_6900; Immune System.
DR   SignaLink; O14733; -.
DR   EvolutionaryTrace; O14733; -.
DR   GeneWiki; MAP2K7; -.
DR   GenomeRNAi; 5609; -.
DR   NextBio; 21802; -.
DR   PMAP-CutDB; O14733; -.
DR   PRO; PR:O14733; -.
DR   ArrayExpress; O14733; -.
DR   Bgee; O14733; -.
DR   CleanEx; HS_MAP2K7; -.
DR   Genevestigator; O14733; -.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008545; F:JUN kinase kinase activity; IEA:Ensembl.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007257; P:activation of JUN kinase activity; ISS:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0072709; P:cellular response to sorbitol; IEA:Ensembl.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:GOC.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome.
DR   GO; GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome.
DR   GO; GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome.
DR   GO; GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome.
DR   GO; GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome.
DR   GO; GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome.
DR   GO; GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   ATP-binding; Coiled coil; Complete proteome; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Stress response; Transferase; Tyrosine-protein kinase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    419       Dual specificity mitogen-activated
FT                                protein kinase kinase 7.
FT                                /FTId=PRO_0000086388.
FT   DOMAIN      120    380       Protein kinase.
FT   NP_BIND     126    134       ATP (By similarity).
FT   REGION       37     57       D domain (By similarity).
FT   REGION      377    400       DVD domain.
FT   COILED        2     30       Potential.
FT   ACT_SITE    243    243       Proton acceptor (By similarity).
FT   BINDING     149    149       ATP (By similarity).
FT   SITE         44     45       Cleavage; by anthrax lethal factor.
FT   SITE         76     77       Cleavage; by anthrax lethal factor.
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     271    271       Phosphoserine; by MAP3K (By similarity).
FT   MOD_RES     275    275       Phosphothreonine; by MAP3K (By
FT                                similarity).
FT   VAR_SEQ      42     42       T -> IIVITLSPAPAPSQRAA (in isoform 3).
FT                                /FTId=VSP_022309.
FT   VAR_SEQ     111    111       Q -> QVPPSLWRGEGGGPARLDPSWERQWGAGGGGRAPGT
FT                                LQPSLSSQ (in isoform 2).
FT                                /FTId=VSP_004883.
FT   VAR_SEQ     312    312       L -> LPCPSPSQ (in isoform 4).
FT                                /FTId=VSP_022310.
FT   VARIANT     118    118       N -> S (in dbSNP:rs56316660).
FT                                /FTId=VAR_040825.
FT   VARIANT     138    138       R -> C (in dbSNP:rs56106612).
FT                                /FTId=VAR_040826.
FT   VARIANT     162    162       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040827.
FT   VARIANT     162    162       R -> H (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040828.
FT   VARIANT     195    195       A -> T (in dbSNP:rs55800262).
FT                                /FTId=VAR_040829.
FT   VARIANT     259    259       L -> F (in dbSNP:rs1053566).
FT                                /FTId=VAR_029890.
FT   CONFLICT     94     94       Q -> H (in Ref. 2; AAB97813).
FT   CONFLICT    106    106       L -> P (in Ref. 4; ABE03013).
FT   CONFLICT    133    133       Q -> P (in Ref. 2; AAB97813).
FT   CONFLICT    142    142       T -> N (in Ref. 1; AAB88048).
FT   CONFLICT    407    407       S -> N (in Ref. 2; AAB97813).
FT   CONFLICT    415    415       L -> LG (in Ref. 2; AAB97813).
FT   STRAND      105    114
FT   HELIX       117    119
FT   STRAND      120    125
FT   STRAND      134    139
FT   TURN        140    142
FT   STRAND      145    152
FT   HELIX       157    172
FT   TURN        173    175
FT   STRAND      182    187
FT   STRAND      189    196
FT   STRAND      200    202
FT   HELIX       203    210
FT   HELIX       216    237
FT   HELIX       246    248
FT   STRAND      249    251
FT   STRAND      257    259
FT   HELIX       286    289
FT   HELIX       302    317
FT   TURN        321    324
FT   HELIX       328    337
FT   STRAND      345    347
FT   HELIX       351    360
FT   TURN        365    367
FT   HELIX       371    374
FT   HELIX       378    385
FT   HELIX       390    399
SQ   SEQUENCE   419 AA;  47485 MW;  F1B22E050F54299A CRC64;
     MAASSLEQKL SRLEAKLKQE NREARRRIDL NLDISPQRPR PTLQLPLAND GGSRSPSSES
     SPQHPTPPAR PRHMLGLPST LFTPRSMESI EIDQKLQEIM KQTGYLTIGG QRYQAEINDL
     ENLGEMGSGT CGQVWKMRFR KTGHVIAVKQ MRRSGNKEEN KRILMDLDVV LKSHDCPYIV
     QCFGTFITNT DVFIAMELMG TCAEKLKKRM QGPIPERILG KMTVAIVKAL YYLKEKHGVI
     HRDVKPSNIL LDERGQIKLC DFGISGRLVD SKAKTRSAGC AAYMAPERID PPDPTKPDYD
     IRADVWSLGI SLVELATGQF PYKNCKTDFE VLTKVLQEEP PLLPGHMGFS GDFQSFVKDC
     LTKDHRKRPK YNKLLEHSFI KRYETLEVDV ASWFKDVMAK TESPRTSGVL SQPHLPFFR
//


ID   KKCC1_RAT               Reviewed;         505 AA.
AC   P97756; Q64572; Q794E3;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   19-MAR-2014, entry version 105.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase kinase 1;
DE            Short=CaM-KK 1;
DE            Short=CaM-kinase kinase 1;
DE            Short=CaMKK 1;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM-kinase IV kinase;
DE   AltName: Full=Calcium/calmodulin-dependent protein kinase kinase alpha;
DE            Short=CaM-KK alpha;
DE            Short=CaM-kinase kinase alpha;
DE            Short=CaMKK alpha;
GN   Name=Camkk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 214-230 AND 291-310,
RP   FUNCTION, ENZYME REGULATION, INTERACTION WITH CALMODULIN, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7642608; DOI=10.1074/jbc.270.33.19320;
RA   Tokumitsu H., Enslen H., Soderling T.R.;
RT   "Characterization of a Ca2+/calmodulin-dependent protein kinase
RT   cascade. Molecular cloning and expression of calcium/calmodulin-
RT   dependent protein kinase kinase.";
RL   J. Biol. Chem. 270:19320-19324(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8827455;
RA   Okuno S., Kitani T., Fujisawa H.;
RT   "Evidence for the existence of Ca2+/calmodulin-dependent protein
RT   kinase IV kinase isoforms in rat brain.";
RL   J. Biochem. 119:1176-1181(1996).
RN   [3]
RP   PROTEIN SEQUENCE OF 4-13; 20-38; 50-60; 137-148; 196-210; 275-288;
RP   291-311; 333-340; 351-360; 365-382; 389-397; 405-408; 440-444; 458-468
RP   AND 473-478, FUNCTION IN PHOSPHORYLATION OF CAMK1 AND CAMK4, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=8631893; DOI=10.1074/jbc.271.18.10806;
RA   Edelman A.M., Mitchelhill K.I., Selbert M.A., Anderson K.A.,
RA   Hook S.S., Stapleton D., Goldstein E.G., Means A.R., Kemp B.E.;
RT   "Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat
RT   brain. Purification, regulation by Ca(2+)-calmodulin, and partial
RT   amino acid sequence.";
RL   J. Biol. Chem. 271:10806-10810(1996).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=8929978; DOI=10.1016/0304-3940(96)12317-X;
RA   Nakamura Y., Okuno S., Kitani T., Otake K., Sato F., Fujisawa H.;
RT   "Distribution of Ca2+/calmodulin-dependent protein kinase kinase alpha
RT   in the rat central nervous system: an immunohistochemical study.";
RL   Neurosci. Lett. 204:61-64(1996).
RN   [5]
RP   CHARACTERIZATION.
RX   PubMed=9335539; DOI=10.1021/bi971348i;
RA   Tokumitsu H., Wayman G.A., Muramatsu M.-A., Soderling T.R.;
RT   "Calcium/calmodulin-dependent protein kinase kinase: identification of
RT   regulatory domains.";
RL   Biochemistry 36:12823-12827(1997).
RN   [6]
RP   PHOSPHORYLATION AT THR-108 AND SER-458, MUTAGENESIS OF THR-108 AND
RP   SER-458, AND PHOSPHORYLATION BY PRCAKA.
RX   PubMed=9195898; DOI=10.1074/jbc.272.26.16073;
RA   Wayman G.A., Tokumitsu H., Soderling T.R.;
RT   "Inhibitory cross-talk by cAMP kinase on the calmodulin-dependent
RT   protein kinase cascade.";
RL   J. Biol. Chem. 272:16073-16076(1997).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF AKT1.
RX   PubMed=9859994; DOI=10.1038/25147;
RA   Yano S., Tokumitsu H., Soderling T.R.;
RT   "Calcium promotes cell survival through CaM-K kinase activation of the
RT   protein-kinase-B pathway.";
RL   Nature 396:584-587(1998).
RN   [8]
RP   PHOSPHORYLATION AT SER-74 AND THR-108, MUTAGENESIS OF SER-74 AND
RP   THR-108, PHOSPHORYLATION BY PRCAKA, AND TISSUE SPECIFICITY.
RX   PubMed=10187789; DOI=10.1074/jbc.274.15.10086;
RA   Matsushita M., Nairn A.C.;
RT   "Inhibition of the Ca2+/calmodulin-dependent protein kinase I cascade
RT   by cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 274:10086-10093(1999).
RN   [9]
RP   MUTAGENESIS OF ARG-172 AND ARG-177, DOMAIN RP, AND INTERACTION WITH
RP   CAMK4.
RX   PubMed=10336483; DOI=10.1074/jbc.274.22.15803;
RA   Tokumitsu H., Takahashi N., Eto K., Yano S., Soderling T.R.,
RA   Muramatsu M.-A.;
RT   "Substrate recognition by Ca2+/Calmodulin-dependent protein kinase
RT   kinase. Role of the arg-pro-rich insert domain.";
RL   J. Biol. Chem. 274:15803-15810(1999).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10651863; DOI=10.1046/j.1460-9568.2000.00883.x;
RA   Sakagami H., Umemiya M., Saito S., Kondo H.;
RT   "Distinct immunohistochemical localization of two isoforms of
RT   Ca2+/calmodulin-dependent protein kinase kinases in the adult rat
RT   brain.";
RL   Eur. J. Neurosci. 12:89-99(2000).
RN   [11]
RP   STRUCTURE BY NMR OF 438-463 IN COMPLEX WITH CA(2+)/CALMODULIN, AND
RP   MUTAGENESIS OF PHE-459 AND PHE-463.
RX   PubMed=10467092; DOI=10.1038/12271;
RA   Osawa M., Tokumitsu H., Swindells M.B., Kurihara H., Orita M.,
RA   Shibanuma T., Furuya T., Ikura M.;
RT   "A novel target recognition revealed by calmodulin in complex with
RT   Ca2+-calmodulin-dependent kinase kinase.";
RL   Nat. Struct. Biol. 6:819-824(1999).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that belongs
CC       to a proposed calcium-triggered signaling cascade involved in a
CC       number of cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G
CC       and CAMK4. Involved in regulating cell apoptosis. Promotes cell
CC       survival by phosphorylating AKT1/PKB that inhibits pro-apoptotic
CC       BAD/Bcl2-antagonist of cell death.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may relieve intrasteric autoinhibition. Partially
CC       inhibited upon phosphorylation by PRCAKA/PKA. May be regulated
CC       through phosphorylation by CAMK1 and CAMK4.
CC   -!- SUBUNIT: Interacts with CAMK4 and calmodulin.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- TISSUE SPECIFICITY: Mostly expressed in the brain with higher
CC       levels in cortex and hippocampus. Lower expression levels were
CC       detected in striatum, nucleus accumbens and cerebellum (at protein
CC       level). Abundant in forebrain, weaker in cerebellum and also
CC       detected in thymus and spleen.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin
CC       binding region and may be involved in intrasteric autoinhibition.
CC   -!- DOMAIN: The RP domain (arginine/proline-rich) is involved in the
CC       recognition of CAMKI and CAMK4 as substrates.
CC   -!- PTM: Appears to be autophosphorylated. Phosphorylated at multiple
CC       sites by PRCAKA/PKA. Phosphorylation of Ser-458 is blocked upon
CC       binding to Ca(2+)/calmodulin. May be phosphorylated by CAMK1 and
CC       CAMK4.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42810; AAC42070.1; -; mRNA.
DR   EMBL; AB023658; BAA75246.1; -; mRNA.
DR   EMBL; S83194; AAB46910.1; -; mRNA.
DR   PIR; A57156; A57156.
DR   RefSeq; NP_113850.1; NM_031662.1.
DR   UniGene; Rn.4851; -.
DR   PDB; 1CKK; NMR; -; B=438-463.
DR   PDBsum; 1CKK; -.
DR   ProteinModelPortal; P97756; -.
DR   SMR; P97756; 438-463.
DR   IntAct; P97756; 4.
DR   MINT; MINT-1203156; -.
DR   PhosphoSite; P97756; -.
DR   PaxDb; P97756; -.
DR   PRIDE; P97756; -.
DR   GeneID; 60341; -.
DR   KEGG; rno:60341; -.
DR   CTD; 84254; -.
DR   RGD; 62023; Camkk1.
DR   eggNOG; COG0515; -.
DR   HOGENOM; HOG000007846; -.
DR   HOVERGEN; HBG052262; -.
DR   InParanoid; P97756; -.
DR   KO; K07359; -.
DR   EvolutionaryTrace; P97756; -.
DR   NextBio; 611998; -.
DR   PRO; PR:P97756; -.
DR   Genevestigator; P97756; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:RGD.
DR   GO; GO:0032147; P:activation of protein kinase activity; IDA:RGD.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    505       Calcium/calmodulin-dependent protein
FT                                kinase kinase 1.
FT                                /FTId=PRO_0000086143.
FT   DOMAIN      128    409       Protein kinase.
FT   NP_BIND     134    142       ATP (By similarity).
FT   REGION      167    189       RP domain.
FT   REGION      435    440       Autoinhibitory domain.
FT   REGION      438    463       Calmodulin-binding.
FT   ACT_SITE    275    275       Proton acceptor (By similarity).
FT   BINDING     157    157       ATP (By similarity).
FT   MOD_RES      74     74       Phosphoserine.
FT   MOD_RES     108    108       Phosphothreonine.
FT   MOD_RES     458    458       Phosphoserine.
FT   MOD_RES     492    492       Phosphoserine (By similarity).
FT   MUTAGEN      74     74       S->A: Decrease in phosphorylation by PKA.
FT   MUTAGEN     108    108       T->A: Decrease in phosphorylation and
FT                                partial inhibition by PKA. Almost loss of
FT                                inhibition by PKA; when associated with
FT                                A-458.
FT   MUTAGEN     172    172       R->E: Loss of substrate recognition and
FT                                interaction with CAMK4.
FT   MUTAGEN     177    177       R->E: Loss of substrate recognition and
FT                                interaction with CAMK4.
FT   MUTAGEN     458    458       S->A: Decrease in phosphorylation and
FT                                partial inhibition by PKA. Almost loss of
FT                                inhibition by PKA; when associated with
FT                                A-108.
FT   MUTAGEN     459    459       F->D: Loss of binding to
FT                                Ca(2+)/calmodulin.
FT   MUTAGEN     463    463       F->D: Loss of binding to
FT                                Ca(2+)/calmodulin.
FT   CONFLICT     45     45       P -> S (in Ref. 1; AAC42070).
FT   CONFLICT     81     81       G -> E (in Ref. 1; AAC42070).
FT   HELIX       444    453
FT   STRAND      455    457
SQ   SEQUENCE   505 AA;  55908 MW;  6B268780AC9B67E1 CRC64;
     MERSPAVCCQ DPRAELVERV AAISVAHLEE AEEGPEPASN GVDPPPRARA ASVIPGSASR
     PTPVRPSLSA RKFSLQERPA GSCLEAQVGP YSTGPASHMS PRAWRRPTIE SHHVAISDTE
     DCVQLNQYKL QSEIGKGAYG VVRLAYNERE DRHYAMKVLS KKKLLKQYGF PRRPPPRGSQ
     APQGGPAKQL LPLERVYQEI AILKKLDHVN VVKLIEVLDD PAEDNLYLVF DLLRKGPVME
     VPCDKPFPEE QARLYLRDII LGLEYLHCQK IVHRDIKPSN LLLGDDGHVK IADFGVSNQF
     EGNDAQLSST AGTPAFMAPE AISDTGQSFS GKALDVWATG VTLYCFVYGK CPFIDEYILA
     LHRKIKNEAV VFPEEPEVSE ELKDLILKML DKNPETRIGV SDIKLHPWVT KHGEEPLPSE
     EEHCSVVEVT EEEVKNSVKL IPSWTTVILV KSMLRKRSFG NPFEPQARRE ERSMSAPGNL
     LLKEGCGEGG KSPELPGVQE DEAAS
//


ID   Q90WS6_9SAUR            Unreviewed;       215 AA.
AC   Q90WS6;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   16-OCT-2013, entry version 58.
DE   RecName: Full=Pyruvate kinase;
DE            EC=2.7.1.40;
DE   Flags: Fragment;
GN   Name=pyruvate kinase;
OS   Elaphe sp.
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Colubridae; Colubrinae; Elaphe.
OX   NCBI_TaxID=114965;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RA   Hughes S.N.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RA   Hughes S., Laurin M., Gouy M., Mouchiroud D.;
RT   "The phylogenetic position of turtles among sauropsidae remains
RT   contentious with new nuclear data.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + pyruvate = ADP + phosphoenolpyruvate.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 5/5.
CC   -!- SIMILARITY: Belongs to the pyruvate kinase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ286864; CAC69539.1; -; mRNA.
DR   ProteinModelPortal; Q90WS6; -.
DR   HOVERGEN; HBG000941; -.
DR   UniPathway; UPA00109; UER00188.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0004743; F:pyruvate kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006096; P:glycolysis; IEA:UniProtKB-UniPathway.
DR   Gene3D; 2.40.33.10; -; 1.
DR   Gene3D; 3.20.20.60; -; 1.
DR   InterPro; IPR001697; Pyr_Knase.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom.
DR   InterPro; IPR018209; Pyrv_Knase_AS.
DR   InterPro; IPR015793; Pyrv_Knase_brl.
DR   InterPro; IPR015806; Pyrv_Knase_insert_dom.
DR   PANTHER; PTHR11817; PTHR11817; 1.
DR   Pfam; PF00224; PK; 1.
DR   PRINTS; PR01050; PYRUVTKNASE.
DR   SUPFAM; SSF50800; SSF50800; 1.
DR   SUPFAM; SSF51621; SSF51621; 1.
DR   PROSITE; PS00110; PYRUVATE_KINASE; 1.
PE   2: Evidence at transcript level;
KW   Glycolysis; Kinase; Magnesium; Pyruvate; Transferase.
FT   NON_TER       1      1
FT   NON_TER     215    215
SQ   SEQUENCE   215 AA;  23520 MW;  50FED93ADFDA0C15 CRC64;
     KGSGTAEVEL KKGATLKVTL DNAYMEKCDE HVLWVDYKNI IKVVEIGSKI YVDDGLISLK
     VKEKGADFIM TEIENGGLLG SKKGVNLPGA AVDLPAVPEK DIQDLKFGVE QDVDMVLASF
     IRKAADVHAV RKVLGEKGKN IKIISKIENH EGVRRFDEIM EASDGIMVAR GDLGIEIPAE
     KVFLAQKMMI GRCNRAGKPI ICATQMLESM IKKPP
//



